Literature DB >> 19384188

The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma.

Alcides Chaux1, Carmelo Caballero, Fernando Soares, Gustavo C Guimarães, Isabel W Cunha, Víctor Reuter, José Barreto, Ingrid Rodríguez, Antonio L Cubilla.   

Abstract

A concern of surgical oncologists has been to find a method to select patients for groin dissection in penile carcinomas considering the high morbidity of this procedure. A promising methodology, in the identification of early metastatic foci by the sentinel lymph node technique (initiated in Paraguay in the 1970s), was found, using a static anatomic approach, to be associated with a recurrence rate of 30%. Later, a dynamic method using radioactive tracers and peritumoral dye injection was introduced with an improvement in patients' outcome. Recurrences, however, remained high in most studies at a rate of about 15% to 20% except in few highly specialized centers with failure rates of 5%. The technical sophistication, lack of multicenter reproduction, and cost of dynamic sentinel node biopsies preclude their routine implementation in developing countries and other approaches are necessary. Because histologic grade, depth of tumor infiltration, and perineural invasion (PNI) are considered among the most important pathologic prognostic parameters in penile cancer, we devised a Prognostic Index combining these 3 factors. In this study, we are evaluating the incidence of nodal metastasis according to the Prognostic Index score. Pathologic materials from 193 patients with penectomy/circumcision and bilateral groin dissections for invasive squamous cell carcinoma were analyzed. The Prognostic Index (ranging from 2 to 7) consisted in the addition of numerical values given to histologic grade (1 to 3), deepest anatomic level involved by cancer (1 to 3), and presence of PNI (0 or 1). Histologic grades were defined as follows: grade 1, carcinomas with minimal to no atypias; grade 3, tumors showing any proportion of anaplastic cells; and grade 2, the remainder tumors. The anatomic levels and their numerical values were: in glans, lamina propria, 1; corpus spongiosum, 2; and corpus cavernosum, 3. In foreskin they were: lamina propria, 1; dartos, 2; and skin, 3. PNI was evaluated as follows: absence of PNI, 0; presence of PNI, 1. Penile intraepithelial neoplasia (carcinoma in situ), or index 1, was excluded from the study. Mean follow-up obtained in all patients was of 81 months. The distribution of cases and rate of metastasis according to index scores were: 2 (1 case), no metastasis; 3 (17 cases), no metastasis; 4 (35 cases), 20% of metastasis; 5 50 cases), 50% of metastasis; 6 (47 cases), 66% of metastasis; and 7 (43 cases), 79% of metastasis. On logistic regression analysis evaluating various pathologic factors, Prognostic Index scores were found as the best predictors of inguinal node metastasis and patients' survival. Inguinal node dissections might not be necessary for patients with low indices (2 and 3). Nodal dissections might be formally indicated for high-grade indexes (5 to 7). Patients with index 4 should be individually assessed for nodal dissection. If sentinel node biopsy cannot be performed for various reasons the Prognostic Index might represent a useful pathologic guide to the clinicians in the often difficult decision to perform an inguinal dissection or not.

Entities:  

Mesh:

Year:  2009        PMID: 19384188     DOI: 10.1097/PAS.0b013e31819d17eb

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

Review 1.  Contemporary management of patients with penile cancer and lymph node metastasis.

Authors:  Andrew Leone; Gregory J Diorio; Curtis Pettaway; Viraj Master; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

Review 2.  [Pathology and histopathological evaluation of penile cancer].

Authors:  A Erbersdobler
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

3.  Penile cancer: impact of age at diagnosis on morphology and prognosis.

Authors:  Geise Rezende Paiva; Iguaracyra Barreto de Oliveira Araújo; Daniel Abensur Athanazio; Luiz Antonio Rodrigues de Freitas
Journal:  Int Urol Nephrol       Date:  2014-11-11       Impact factor: 2.370

4.  Mixed papillary-sarcomatoid carcinoma of the penis: report of an aggressive subtype.

Authors:  Graziele Bovolim; Walter Henriques da Costa; Gustavo Cardoso Guimaraes; Fernando Augusto Soares; Isabela Werneck da Cunha
Journal:  Virchows Arch       Date:  2017-07-08       Impact factor: 4.064

Review 5.  What Is New in the Diagnosis and Management of Penile Cancer?

Authors:  Pal Mahendra; Bakshi Ganesh; Prakash Gagan; Mahajan Vidisha
Journal:  Indian J Surg Oncol       Date:  2017-02-27

6.  Penile cancer: Optimal management of T1G2 penile cancer remains unclear.

Authors:  Alcides Chaux; Antonio L Cubilla
Journal:  Nat Rev Urol       Date:  2012-12-11       Impact factor: 14.432

7.  18F-FDG PET/CT as a prognostic factor in penile cancer.

Authors:  André Salazar; Eduardo Paulino Júnior; Paulo Guilherme O Salles; Raul Silva-Filho; Edna A Reis; Marcelo Mamede
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-24       Impact factor: 9.236

8.  SOD2 immunoexpression predicts lymph node metastasis in penile cancer.

Authors:  Lara Termini; José H Fregnani; Enrique Boccardo; Walter H da Costa; Adhemar Longatto-Filho; Maria A Andreoli; Maria C Costa; Ademar Lopes; Isabela W da Cunha; Fernando A Soares; Luisa L Villa; Gustavo C Guimarães
Journal:  BMC Clin Pathol       Date:  2015-03-03

9.  Clinicopathologic and outcome features of superficial high-grade and deep low-grade squamous cell carcinomas of the penis.

Authors:  Alcides Chaux
Journal:  Springerplus       Date:  2015-06-09

10.  Tumor histologic grade is the most important prognostic factor in patients with penile cancer and clinically negative lymph nodes not submitted to regional lymphadenectomy.

Authors:  Giuliano Amorim Aita; Stênio de Cássio Zequi; Walter Henriques da Costa; Gustavo Cardoso Guimarães; Fernando Augusto Soares; Thais Safranov Giuliangelis
Journal:  Int Braz J Urol       Date:  2016 Nov-Dec       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.